Podcasts about Genetic

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter Antonio Bianco is a world-renowned physician-scientist and expert in thyroid physiology and metabolism. In this episode, Antonio explores the complex biology of thyroid hormone production, conversion, and regulation—highlighting how deiodinase enzymes modulate hormone activity at the tissue level and why that matters for interpreting lab results. He discusses the shortcomings of relying solely on TSH as a marker of thyroid function, the ongoing debate around combination therapy with T3 and T4 versus standard T4 treatment, and how genetics, tissue sensitivity, and individual variability influence thyroid hormone metabolism. The conversation also examines how hypothyroidism affects energy, mood, cognition, and longevity; why some patients remain symptomatic despite "normal" labs; and how future research could reshape treatment paradigms. We discuss: How the thyroid produces, stores, and activates hormones like T4 and T3 to finely regulate thyroid activity [2:45]; How fasting alters thyroid hormones to conserve energy [12:45]; Action of the deiodinases: how D1, D2, and D3 enzymes control the activation and inactivation of thyroid hormones [19:15]; The normal function of thyroid hormone and the roles of the hypothalamus, pituitary gland, and deiodinases in maintaining hormonal balance [23:30]; Why understanding thyroid physiology is essential for proper diagnosis and treatment of hypothyroidism [33:45]; Testing for thyroid hormones: understanding free vs. total levels, the limitations of current T3 assays, best practices, and more [36:00]; Genetic and sex-based variability in thyroid hormone regulation and their limited clinical significance [43:45]; Hyperthyroidism: causes, symptoms, diagnosis, and treatment options [46:00]; Hypothyroidism: diagnosis and autoimmune causes of hypothyroidism [56:30]; More on hypothyroidism: diagnostic biomarkers, antibody patterns, and non-autoimmune presentations [1:05:00]; Thyroid hormone replacement therapy [1:15:15]; More on thyroid replacement strategies: exploring the evidence gaps, mortality signals, effects on lipids, and more [1:28:00]; Hypothyroidism basics: causes, antibody implications (including pregnancy), and how to make the diagnosis before choosing therapy [1:35:15]; Thyroid medication: compounded controlled-release T3, brand name versus generic, and what Antonio prescribes to newly diagnosed hypothyroid patients [1:42:45]; Redefining treatment success: why normalizing TSH isn't always enough for patients with hypothyroidism [1:54:45]; Case studies: analysis of two unusual cases of thyroid disease [1:57:00]; Dangers of supplementing with high levels of iodine, and female-specific risk of thyroid disease [2:05:45]; Case study of a patient who presents with elevated TSH but no symptoms [2:09:30]; How future research could reshape treatment, and Antonio's new book called "Rethinking Hypothyroidism" [2:13:15]; and More. Connect With Peter on Twitter, Instagram, Facebook and YouTube

Welcome back to Beautifully Broken, where healing meets high performance. Today, I'm joined by the luminous Dr. Shivani Gupta, founder of Fusionary Formulas and author of The Inflammation Code. Shivani's story begins with a home full of mold, hair loss, and a reminder that even the healthiest among us can get blindsided by hidden toxins. What followed was a journey of deep functional medicine testing, emotional regulation, and fierce self-advocacy—proof that healing is never linear.We talk about the real root of “inflamma-aging,” why brain fog and fatigue are not normal, and how inflammation is at the center of most chronic disease. Shivani breaks down the six Ayurvedic pillars of anti-inflammatory living, the importance of circadian alignment (especially the 10–2 window), and why tea time is more than self-care—it's medicine.From tongue scraping and turmeric to sleep hygiene and self-awareness, this episode is full of accessible practices that bring ancient rituals into modern life. Whether you're battling burnout, navigating hormonal chaos, or simply ready to feel more alive, Shivani's wisdom will help you rewrite your own inflammation code. Episode Highlights[00:00] – Living with mold: the surprise diagnosis that changed everything[03:30] – Mold dogs, remediation, and the truth about “healthy homes”[06:40] – Why no supplement can fix a toxic environment[09:10] – Genetic resilience, functional testing, and understanding bio-individuality[13:05] – Hair loss as a metabolic signal and the timeline of toxic exposure[17:00] – Fear, mindset, and emotional regulation during mold recovery[18:52] – The Inflammation Code: aging, Ayurveda, and winning at inflammation[22:45] – Cycles, seasons, and building your Ayurvedic circadian rhythm[26:19] – Mental inflammation: the hidden driver of burnout and disease[30:40] – Building an anti-inflammatory lifestyle from the ground up[36:57] – Why doctors stay in their lanes—and why you must self-advocate[39:22] – Pitta, Kapha, and using fire time for healing and repair[45:24] – Ayurvedic sleep rituals and the power of forgiveness in wellness[47:21] – Tea time is me time: micro-moments of self-care that change your biology[53:37] – The 12 daily rituals for detox, digestion, and emotional balance[55:15] – Tongue scraping, turmeric, and the simple tools that actually work[58:56] – How to cycle supplements, build awareness, and measure results[1:01:26] – The spreadsheet of supplements: data meets intuition[1:03:02] – Big love, big lessons, and the path to sustainable healingConnect With Dr. ShivaniDr. Shivani Gupta: https://drshivani.comThe Inflammation Code (Preorder): https://theinflammationcode.comGet Your UpgradeVisionary Formulas: https://fusionaryformulas.com/?sca_ref=9671297.FAK6ESUdt3R9--- Code: BEAUTIFULLYBROKENThe Biological Blueprint Program: https://www.beautifullybroken.world/Beam Minerals: http://beamminerals.com/beautifullybroken— Code: BEAUTIFULLYBROKENSilver Biotics: bit.ly/3JnxyDD— 30% off with Code: BEAUTIFULLYBROKENLightPathLED: https://lightpathled.pxf.io/c/3438432/2059835/25794— Code: beautifullybrokenCatchBio: https://www.catchbio.com/beautifullybroken — Code: BEAUTIFULLYBROKEN   CONNECT WITH FREDDIEWork with Me: https://www.beautifullybroken.world/biological-blueprintWebsite and Store: (http://www.beautifullybroken.world) Instagram: (https://www.instagram.com/beautifullybroken.world/) YouTube: https://www.youtube.com/@freddiekimmel Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Nearly 7 million Americans currently live with Alzheimer’s and by 2060, experts say that number could be as high as 14 million. Scientists are trying to find out how one man has been able to stave off Alzheimer's for 25 years, despite having a rare genetic mutation that, doctors say, essentially guaranteed he’d develop the disease. Pam Belluck of The New York Times joins Ali Rogin to discuss. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy

Nearly 7 million Americans currently live with Alzheimer’s and by 2060, experts say that number could be as high as 14 million. Scientists are trying to find out how one man has been able to stave off Alzheimer's for 25 years, despite having a rare genetic mutation that, doctors say, essentially guaranteed he’d develop the disease. Pam Belluck of The New York Times joins Ali Rogin to discuss. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy

The Nazi dictator is believed to have had a hidden genetic disorder known as Kallmann syndrome, which can thwart the development of sexual organs, according to a stunning new documentary analyzing his biological makeup. Please Like, Comment and Follow 'Philip Teresi on KMJ' on all platforms: --- Philip Teresi on KMJ is available on the KMJNOW app, Apple Podcasts, Spotify, YouTube or wherever else you listen to podcasts. -- Philip Teresi on KMJ Weekdays 2-6 PM Pacific on News/Talk 580 AM & 105.9 FM KMJ | Website | Facebook | Instagram | X | Podcast | Amazon | - Everything KMJ KMJNOW App | Podcasts | Facebook | X | Instagram See omnystudio.com/listener for privacy information.

Intelligence Note: Cloned Food News (USA and Canada)Weaponised Food (Food Science) Genetic Warfare Canada's and USA's Cloned Meat (Agenda 2030 News)Cloned meat will soon enter Canadian grocery stores without safety reviews or labeling.Health Canada recently scrapped its 22-year-old policy that classified cloned meat as novel foods, removing pre-market safety assessments and allowing these products to be sold with no disclosure.To support the [Show] and its [Research] with Donations, please send all funds and gifts to :$aigner2019 (cashapp) or https://www.paypal.me/Aigner2019 or Zelle (1-617-821-3168). Shalom Aleikhem!

Garrett Schumacher is Business Unit Director of Product Security at Velentium Medical and the co-founder and CTO of GeneInfoSec. Garrett discusses his journey from medical student to cybersecurity expert and educator, dedicating his career to securing medical devices. He shares insights on the intersection of cybersecurity and healthcare, highlighting the challenges of protecting genetic data. Garrett gives honest advice about navigating cybersecurity and data privacy concerns, how to be a good leader, and what medtech startups should consider as they design and develop their devices.    Guest links: https://velentiummedical.com/ | https://www.geneinfosec.com/  Charity supported: Save the Children Interested in being a guest on the show or have feedback to share? Email us at theleadingdifference@velentium.com.  PRODUCTION CREDITS Host & Editor: Lindsey Dinneen Producer: Velentium Medical   EPISODE TRANSCRIPT Episode 068 - Garrett Schumacher [00:00:00] Lindsey Dinneen: Hi, I'm Lindsey and I'm talking with MedTech industry leaders on how they change lives for a better world. [00:00:09] Diane Bouis: The inventions and technologies are fascinating and so are the people who work with them. [00:00:15] Frank Jaskulke: There was a period of time where I realized, fundamentally, my job was to go hang out with really smart people that are saving lives and then do work that would help them save more lives. [00:00:28] Diane Bouis: I got into the business to save lives and it is incredibly motivating to work with people who are in that same business, saving or improving lives. [00:00:38] Duane Mancini: What better industry than where I get to wake up every day and just save people's lives. [00:00:42] Lindsey Dinneen: These are extraordinary people doing extraordinary work, and this is The Leading Difference. Hello and welcome back to another episode of the Leading Difference Podcast. I'm your host, Lindsey, and today I am excited to introduce you to my guest, Garrett Schumacher. Garrett is the Business Unit Director of Product Security at Velentium Medical, where he has led the cybersecurity efforts on 200 plus medical device products and systems. He is the co-founder and CTO of GeneInfoSec, a startup focused on securing the world's most valuable and private data, our genetic information. In his work, Garrett has trained engineers, developers, manufacturers, healthcare delivery organizations, and laboratories across the globe in cybersecurity, and is an active member of several related industry working groups. He also teaches secure product development and medical device cybersecurity at the graduate level for the University of Colorado Boulder's Department of Computer Science as an adjunct professor in the little bit of time left in his days, Garrett is either rock climbing or spending time with family. Thank you so much for being here, Garrett. I'm so excited to speak with you today. [00:01:48] Garrett Schumacher: Yeah. Thank you for having me. [00:01:49] Lindsey Dinneen: Of course. Well, I'd love, if you wouldn't mind, by starting out and sharing a little bit about yourself and your background and what led you to medtech. [00:01:59] Garrett Schumacher: Yeah. So I guess my background, I mean, it started as I always thought I was gonna be a doctor. I did my undergrad in physiology, thought I was gonna do med school, the whole nine yards. And towards the end of my, let's say junior year, just started being like, "I don't think this is what I want to do." I always had a fascination with tech. I was really involved with a lot of the tech groups on campus at the University of Colorado Boulder, early days of Hack CU, one of the largest collegiate hackathons. And I really regretted not doing a computer science degree, but I was three quarters of the way done. So sometimes you just gotta finish it up, right? Get the degree, find out what's next. After that I went and did a master's in genetics. I wasn't sure exactly what I wanted to do either yet, but hey, a master's degree is not a bad thing to do if you're unsure. And actually I was in a PhD program and dropped out early with a master's. Different story. But yeah. And then I started I helped the University of Colorado Boulder start their cybersecurity programs. So it was getting into the cyber world. I did a, I guess it was a bootcamp, at the University of Denver in cybersecurity. And so that all culminated in me always focusing on healthcare and cybersecurity together. And then COVID happened and that made the world change for a lot of people. And basically I was looking for a new job and I found Velentium, and I think that's where it really spoke to me, where I could do my love of medical and human health with cybersecurity and technology development. And so yeah, I think that's really how I got into it. I had been doing projects related to that before, but Velentium's where it really culminated and I found a place that let me do all the things I love, not just one or the other. [00:03:39] Lindsey Dinneen: That's awesome and such a wonderful gift. So can you share a little bit about what you do now and sort of your growth trajectory even throughout Velentium 'cause I know you've had quite an interesting and exciting career through the company as well. [00:03:56] Garrett Schumacher: Yeah. Yeah. So I started out as a cybersecurity engineer, and just started helping internal projects, external projects with groups that were seeking FDA approval on a medical device and trying to navigate these kind of new cybersecurity requirements. That's where it started. And even since then I've been, so I teach a class at the University of Colorado Boulder on Medical Device Cybersecurity. We're going into our sixth year of that, seventh semester, starting here in the fall. And I also co-founded a startup in the genetic information security space. So, and we can talk about that later. And so I, yeah, talk about what I do. It's all of those things and, it's not, doesn't happen in 40 hours, I promise you that. But after working as a cyber engineer for about a year, I think I got promoted to like Senior Staff Cybersecurity Engineer. Then probably three years ago, I took over more of an operational leadership role within the unit, the team, where I was doing project management and overseeing the other engineers and still doing engineering work. Definitely decided project management is not for the faint of heart and apparently my heart's very faint. It's not for me. So anyways, and then fast forward to just here in like January, February, Velentium made some really awesome changes. They rebranded as Velentium Medical to make sure everyone knew we do medical. And then they created four business units so that they could really say, "Look, we have different core areas of our business. Each of them have their own different operational needs and what have you." So, I was promoted into Business Unit Director of Product Security. And so now we're a business unit. We're a business within a business trying to better serve our clients and implement the processes we need for our small scope of work compared to a large contract development and manufacturing organization. So just that's been my growth goal so far is, come in as an engineer, work my way up to the leadership roles while also still loving to be an educator and and still having my own startup space in the biotech side of the house. [00:05:58] Lindsey Dinneen: Yeah. Excellent. Well, first of all, congratulations on all of that. That is very exciting and it's really fun to see that growth and that development. And I'm also so curious now, can we talk a little bit about your startup? So first of all, let's talk about that and then I wanna talk about the crossover between the two, if that's okay. So. [00:06:16] Garrett Schumacher: Absolutely. Yeah. So, well the name is GeneInfoSec, so it's just short for genetic information security. We're not trying to hide anything there. We focus on protecting the world's most sensitive data. At least that's our opinion is genetic information affects you. And the data you have today is not gonna be any different, for the most part, from the data that you have in, 10, 20, 40 years. But then even beyond that it's partially your children's data, your grandchildren, great-grandchildren, and then even on the, in the inverse, all the way up to your great-great-grandparents, right? You share some, to an extent, some genetic makeup with them. And so it's this really interesting space where networked privacy is-- it's a very different form of networked privacy. It's not just that I upload a photo to LinkedIn and now I could be implicating someone else that's in the photo. It's, I share my info, and I'm also sharing info that belongs to my cousins in, in, in a sense. And so if you think of the Golden State Killer case in California, that was a really interesting one where the federal authorities had genetic information or samples from a cold case in the eighties. And they sequenced that. They uploaded it to a third party, an open public genetic database, and said, "Hey, here's my data. Who am I related to?" And through that they were able to triangulate like, "Okay here it is. This is the guy that did it" many years later. So, there's a case where it's, there could be positives. We want to use it to find that kind of information and protect people. But at the same time, that brings up a lot of privacy implications. And then you can go all the way to the extreme, the sci-fi of designer bio weapons, maybe tailored to certain persons or ethnicities or groups of people. So during grad school, a couple guys and I, we founded this startup, and that's what we focus on through a technology that really our founder, Dr. Sterling Sawaya, he invented, called molecular encryption. It's a way of encrypting molecules before we generate data from them so that the generated genetic data is already, quote unquote encrypted, or at least protected in some manner. So, so that's what we do. And yeah, I guess why we do it a bit. [00:08:27] Lindsey Dinneen: Yeah. Wow. So, okay, so that brings up a really interesting question. I can guess the answer to this, but is there any safe way to-- this is a funny way to put it-- but recreationally to test your genetic data in the sense of the way that a lot of us would think about it in terms of, "Oh, I'd really love to learn more about my ancestors and things like that." But there are so many security concerns, like you've pointed out. So is there any quote unquote, safe way to do so at this time? [00:08:58] Garrett Schumacher: You know that-- it's a great question. There's been a lot of things going on in the news recently, like with, I'm sure people have heard of 23 & Me, and how they went bankrupt and now a company called Regeneron is buying them and all their assets for a lot of money, but not that much compared to what 23 & Me was worth a few years ago. So that brings up a lot of issues, right? 23 & Me still owns a lot of samples, like maybe around 10 million samples. And the sequencing they've been doing is very small. So if your genome's a whole book, they've been kind of flipping through the pages and picking specific letters, and that's the data they have. So that's not the most sensitive, it's not the full story. But if you have the samples, you can always generate the full book someday. And as that cost of full human genome sequencing decreases rapidly, someone's probably gonna want to do that someday. So, okay, so back to your question though, is there a safe way? What I would say is that I, I don't tell people not to do it. I would say if you have health reasons, concerns, and your doctor suggests a genetic test, a lot of those tests are also that similar, picking a few letters, a few known letters and trying to just read that for a very specific purpose. If your doctor and you come to the agreement that you should do that, you should just do that. However, I do not promote, and even to my family members, I highly don't recommend, using these services. I used to really love who's that group out of Utah? Ancestry.com. They used to be a great group. They were trying to sequence the world's DNA for understanding basically the family tree of everyone. Because anyways, they have interest in understanding who's related to who and how that relates to their religion. So they used to do it for internal purposes, keep it on pretty tight, secure. Well then, they sold to a venture capital group. So, it's really tough to say that there's these groups that there's a good place out there to do it. There are some companies that have security or privacy focused DNA sequencing services. But it's really odd, like you have to set up a cryptocurrency account, pay with cryptocurrency, set up a PO box so that you're not like actually shipping to and from your home. And then ultimately the price of it and how they're getting it to be cost effective is China's doing the sequencing. So you do all those privacy measures and your sample gets sent off to another country. And the FBI has disclosed that they know that when certain countries like that are doing the sequencing, whether you want them to do a little tiny test, like a COVID test or whatever it is, they're sequencing the whole thing. They're keeping the data. This is known, disclosed, not conjecture. So, yeah, so sorry-- long-winded answer of saying, I'm interested too, I wanna learn about this. I've got family members that have done it. But right now I recommend just thinking very carefully and critically about whether the immediate fun of it is worth the potential long-term impacts, and maybe if you're someone that's security or privacy conscious, maybe wait a few years because there are some things on the horizon that will make this a lot better. [00:12:02] Lindsey Dinneen: All right! Thank you for the honest answer. I really appreciate it. So, okay, I wanna go back to your work with Velentium specifically and talk about-- you've gotten to work with so many different clients over the years and you've seen so many different variations on a theme. And I'm curious, what are some of the common mistakes or pitfalls you might see a younger startup make when they are perhaps first designing their device, and cybersecurity is maybe not quite top of mind. So what are some of the things that you see that are challenges we can overcome? [00:12:41] Garrett Schumacher: Yeah I think one of the biggest challenges is that a lot of people aren't maybe aware yet of the scrutiny and the requirements that the FDA-- and not just FDA, but the European union's medical device regulations and the bodies over there that review submissions. And any, if you look across the board, pretty much almost every regulatory market has, very much in the last couple years, placed a lot of scrutiny on cybersecurity. So a lot of companies, especially smaller ones starting out in the space, may not be aware of this. And so then oftentimes they'll find out too late, they'll submit. They'll get feedback back, "Oh no, we have 90 days to respond and we didn't do cyber. We gotta do cyber now." And they don't know how to spell it yet, which is a joke. But there's that. And then there's also, or they'll get in just late at the game, "Hey, we're submitting in a month or three" and "Oh, we gotta do this thing retroactively." And so then therefore, we haven't been able to support someone through the full process, at the proper time, doing the right design things to inform the design during the design, not after. So I think that's probably the biggest mistake is not seeking that external support early and often. And if you're getting that, it shouldn't just be someone that can help you navigate the regulatory space. It shouldn't be someone that can just do the pen testing for you at the end. Really I think in that context, you need a partner that can do everything end to end. So that's what we've really tried to make our processes and our services geared towards is being that partner. And whether you have the bandwidth and you will do a lot of the documentation and work, but you just need someone to guide you, consult you, give you the materials to do so, or if you are truly looking for, no, we need to augment our own team and have you do a lot more of the work for us. That's great. We can do that. So, so that's, I think, the biggest challenge. And I think that the answer is just getting the right partner early and working with them often throughout that entire development, not at the end. [00:14:37] Lindsey Dinneen: Yeah, absolutely. And I really appreciate that perspective. I think that there's a lot more awareness, it seems like even in the industry that, "Oh, cybersecurity is a thing now." But as you said, getting to partner with somebody who does know the ins and outs from the start and can really help guide you through is really critical. Now you do quite a bit of speaking and presenting. You're obviously still teaching a college class and all of those wonderful things. I'm curious how that has played into your career as well, and is that something that you will always want to do? You've got this educator side of you as well. [00:15:13] Garrett Schumacher: Yeah, I mean, I love it. I actually taught at a high school for one year between my master's program and my undergraduate, decided that that's not for me, but that teaching at those higher levels where people are really wanting to be in the room. So now I teach at the graduate level, half of the students will be older than me. And now everybody wants to be there and we can have very mature conversations and they even can challenge me with some really great questions that I'm not ready for, right? And I think the best way to learn is to teach. Absolutely. That's, yeah. I think a lot of people have said that. I completely agree. So I plan to always do that. I mean, I love, even with our internal engineers and external clients, like the idea of helping people understand something and humanizing it for 'em. That's really my big flag I'm waving right now is humanizing it. We don't have to use alphabet soups and crazy language. We can make it easy to understand and we can humanize it for the masses. So that's really what I'm trying to do, one of my big pushes. And so I don't foresee myself ever going away from that, I even do a lot of international training on the cyber biosecurity space where I go to all these countries and these biosafety laboratories and help biologists understand cybersecurity as a fundamental practice and how they can improve their personal security, their professional security. And to me that's the most rewarding thing. [00:16:36] Lindsey Dinneen: Yeah. Oh my goodness. That's so cool. Thank you for sharing about that. So, as you are looking towards the future in the industry itself, but also I suppose your own career, what are some things that you're excited about? What are some trends that you see as being positive? I know that, recently, it's been a little bit challenging-- as a nice word-- for a lot of medical device companies and they're a little worried about funding and those kinds of things, and so, that's maybe a trend that's a little not as fun, but what are the things that are empowering and exciting to you as we move forward? [00:17:13] Garrett Schumacher: So not to make it about artificial intelligence or machine learning, 'cause everybody does. It's definitely, its hype curve. But that is actually one of the things that I think I'm most excited about, but also most scared about. We've seen a lot of companies with layoffs because they believe this artificial intelligence enables them to be more efficient and therefore they can do more with fewer people. And that saves money. And I understand that. I think that one of my big pushes right now is trying to help people understand that AI, at least right now, it's not taking over human jobs-- that it can instead augment, improve how we do those jobs. But people have to be ready for it. So even in, in my own space, like, making sure that our team and our people are ready for that. Because if you aren't getting into that space, if you aren't with the curve, then you're gonna fall behind. And yes, you could be replaced in that sense that someone has done it and so now they're doing it better than you. And so if you're not using these tools, these resources to, to improve your efficiency and to just maximize your capability-- like for example, my team, maybe I don't need to hire a person. Maybe we can build out things that enable us to, with the same amount of people, to better serve more clientele. So that's what I'm really trying to navigate. But it is scary thinking about that future and am I even gonna be ready and technically savvy enough to navigate that new future in the next year, in the next five, 10 years. And especially as someone who I've always had this, this goal of maybe someday, and I'm getting talked out of it very quickly, but maybe like being a Chief Information Security Officer at a large company or a Chief Product Security Officer, something like that. And yeah, quickly, I'm-- "Eh, we'll see." But it's those kind of things that, if we can navigate them correctly, may maybe that is something in my future. So that's, I think, one of my big fears and also passion projects right now. And then also, same on that funding vein-- with my startup, we're experiencing that as well. And we actually, we had a lot of funding potential pre COVID. And then even though our technology-- like in some ways COVID brought the need for our technology to the forefront of people's minds-- it also killed a lot of funding opportunity. And so yeah, I mean, navigating that space of how do you get funding and then does it come from venture capital backed or equity, private equity, and I've seen those worlds. I even advise startups. So I mean, that is also probably one of the biggest challenges I'm facing currently as well. [00:19:41] Lindsey Dinneen: Yeah. Yeah. It's gonna be really interesting to see how things evolve, and it's been fascinating to read the news and see even the headlines where it's like, the FDA is using AI to review submissions and all sorts of things, and you really do wonder how we'll move forward and time will tell, I suppose. [00:20:01] Garrett Schumacher: Yeah. [00:20:02] Lindsey Dinneen: So you have stepped into quite a number of leadership roles fairly young in your career, if you don't mind me just saying so, and so I'm curious how you have navigated that growth for yourself. First of all, do you feel like you were a natural leader or were those skills things you developed along the way? And secondly, what advice might you have for younger leaders? [00:20:27] Garrett Schumacher: Great questions. Yeah, definitely nothing is natural about it. I think for anyone, I mean, it's nothing that you just do and you're just like, "Yep, I'm a leader. That's easy." So it definitely something, just like all aspects of work and maturity, is you have to work on it. But I think how I got there was-- and someone told me a couple tips early in my career, I suppose-- and it was a couple are: find a mentor, and as the mentee you have to put in the effort. If you set up meetings and they're not there, whatever, like they're busy, and you are asking them to give their time for you. So, find mentors and then be a good mentee, meet up with them. I had several people that were critical in my early career. One was Bunky Davis and she was amazing. She was no longer with us, but her and I grabbed coffee every single month. She had navigated biotech startups for like 50 years, was also just a phenomenal cyclist, Olympian, like just amazing. And we'd meet up every month for coffee without missing. And we did that for several years. And, and I had another mentor from the University of Colorado Boulder, Lloyd Thrall, who came from the Department of Defense, and just a spectacular, stellar guy, and we would go meet up all the time. And so learning from these people I think I saw-- well, there's that. And then everybody has their bosses and their horror stories from work, whether that's a high school job or professional later on. And so you see the ways that people can be, you don't want to be. And so that, that makes it easy. But without having those mentors, yeah, I don't know if I would've exposed myself to the good ways, right, and the better ways, and be challenged. So that was really critical was finding a good mentor and then being a good mentee. And then I think the other thing is interacting with people and just listening, active listening. So going to the professional shows and meeting people, listening to them, reading a lot of great books out there on how to be a leader, and you don't take all that exactly word for word, but there are golden little nuggets that you can just pick up out of all those things. So, no, definitely something that I have actively worked on and still am trying to work on. And then I'm constantly trying to listen and being that, have that open door policy for my people too. Because if I hire really smart people, I want them to do the thinking and therefore I need to listen. [00:22:44] Lindsey Dinneen: There you go. I love it. All right, so. You've had a really interesting and exciting career so far, and you're obviously very passionate about medtech and cybersecurity and biotech and all those things, and I'm wondering if along the way there are any moments that really stand out to you as affirming, "Wow, I am in the right place at the right time." [00:23:09] Garrett Schumacher: Yeah. Yeah. One was we had a really special project where and I won't give any names away, but basically my stepmother has an implant inside of her and it's it's not life sustaining, but it's one that you want working just so that your body's working normally, and so that you're not, not embarrassed. You can go into public spaces and be a normal person, right? And whether it's pain management, incontinence, those kind of things. So she had this implant and it was, she had one that came from the leading provider of that at the time. And it, the battery life, right, is supposed to last like 10 or 15 years, and it seemed like pretty much seven or eight was all she was getting out of it. And after decades of having far more surgeries than she needed, all the way up to the very last device she got in her-- it failed within the first year, I think-- so it was like, okay, time to pivot. And we found this new company and they've become a huge leader in the space, recently acquired by another one of the big leaders in medtech in general. And we were hired to do the security work for that project. And the only reason that I actually found out-- because my stepmother was literally like in the process of getting this new device inside of her-- I was at that client's facility doing a pen testing and security testing engagement and some consulting and just visiting them. And I FaceTimed my family in the break room and there was a sign behind me and they're like, "Oh my gosh. We're literally, we just got that implanted in your stepmother like, a couple weeks ago. It's working great. She's so happy with it. It's smaller, it works better, all these things." And it's like, "Wow." So I got to lead the security effort and what they're actually doing is adding remote programming capabilities so a doctor can, over the phone, be improving that therapy for you. But that leads to a lot of cybersecurity implications, right? That kind of connectivity. And so I gotta lead the security work on that for something that is in a near and dear, your family member. And it's those kind of things where it's not, you're not just helping patients. It's, I'm helping someone that I care very deeply about. And it hits home differently when it's not just, "Oh, I want this device to be secure. I want them to get FDA clearance. I want whatever." It's, "No, I need now, I need for my own family member for it to be the best." And it's not that project got special scrutiny from us-- we bring that to every project-- but it helps to have the actual experience of one of those projects. [00:25:33] Lindsey Dinneen: Yeah. And to have that real-- well, you were mentioning it-- not just patients that I kept thinking, "Yeah. Not just patients, people," and the idea of it's sometimes probably necessary honestly, to have a little bit of separation from a clinical point of, "I'm helping all of these patients, and that's a really good thing." But then if you could take a step back and go, "And these patients are human beings that rely on what I'm doing for safety and for security and for this lifesaving, life enhancing device." That's-- what a gift to get to experience something like that. [00:26:04] Garrett Schumacher: It is, it's especially like, if you work in the diabetes-- we've had several projects with insulin pumps-- and insulin's a drug that is, highly toxic if given in the wrong dosage. 99% of the world population would die if it's in the wrong dosage if it's too high. And the only reason the other 1% exist is 'cause they're insulin intolerant. They just, they don't respond to insulin and that's why they have their own type of diabetic issues. And I've got several cousins, a brother-in-law, that also use that stuff every day, rely on those kind of technologies. So, yeah, just it's a little bit more special when it's when you get to do that. But we try to do that for everyone. We try to think of everyone's that person that we're trying to help. [00:26:42] Lindsey Dinneen: Yeah, absolutely. All right. Well, this has been so great, but pivoting the conversation a little bit, just for fun. Imagine that you were to be offered a million dollars to teach a masterclass on anything you want. What would you choose to teach and why? [00:26:59] Garrett Schumacher: Ooh. Well, yeah, first of all, a million dollars for-- I feel like I, I'd have to go with something like that I know deeply, very deeply on. But okay, if I wanna have some fun here, I would say rock climbing, because rock climbing is my other big passion. It's the one thing that takes me away from a computer screen typically. And so if you're paying me a million dollars to teach rock climbing, A, these people really wanna learn how to be good rock climbers, so they're gonna be very engaged. And B, that's going to mean that I can go now actually make money on something that has only ever been a passion for me. So, that would be fun. That would be awesome. [00:27:33] Lindsey Dinneen: Awesome. [00:27:33] Garrett Schumacher: If you're offering, Lindsey, I'll accept. [00:27:35] Lindsey Dinneen: Okay, deal, right? Yeah. I'm gonna have to earn my first million first, and then I'll let you know. [00:27:40] Garrett Schumacher: I'll wait. [00:27:41] Lindsey Dinneen: Okay, fair? Fair enough. What got you into rock climbing? [00:27:45] Garrett Schumacher: Oh man. Well, so my mother was, I grew up in like a small farming town in the northeast corner of Colorado. There's not a mountain for, until you get to Denver area, right? In the summers, she worked at the local college, and in the summers she ran the ropes course and they had a giant rock wall. So, I mean, as a 10-year-old, I'm just hanging out there. I didn't know that there was routes or certain ways or techniques. I just, who can get up the fastest, right? But that was always fun. That was my summers. I always, and I was, shoot, I was always told I was a monkey. I was always on stuff climbing something. I've had my share of injuries from it, trust me. And then in college, it just was natural. I went to CU Boulder, as I've probably already said, and a lot of outdoor climbing opportunities. A lot of, they, they built a new gym there inside the school. And so that then it became this thing where, oh, I can actually-- as you move away from high school sports, basketball and American football and those things, you miss that. You can miss some competitiveness and some team-based things. So now I had another active thing that I could-- and I, again, I wasn't so formal in technique or things like that-- so now I could work with people, socialize and work on that technique in something that I was able to do at that level, instead of, I'm not gonna go beat myself up playing football again. So, yeah, I think that's where it came from. And then it's just been my big hobby ever since. And I mean, now I have a bunch of friends down in Austin, Texas, and we go on a big climbing trip once a year, and I see them once a year. It's fun. So it's like expanded my friend group and it keeps me sane. [00:29:14] Lindsey Dinneen: Huh. Excellent. Yes. That's wonderful. All right. How do you wish to be remembered after you leave this world? [00:29:22] Garrett Schumacher: Oh, that's a good one. How do you humbly answer that? When part of the answer I would wanna say is humble, but that's something I always try to work on, is I just wanna be a good guy. I want people to remember that, he was kind, considerate-- would do something at the drop of a hat for you without expecting anything in return-- just kind, generous. And I think a family guy would be a big one. My, my friends and family first and foremost. And maybe second to that, hardworking. Yeah. [00:29:46] Lindsey Dinneen: Yeah. I love that. All right. And final question. What is one thing that makes you smile every time you see or think about it? [00:29:55] Garrett Schumacher: Oh, my wife. I wake up to her every day and that's she's the best part about everything. So yeah, she's my favorite person, and I'm lucky enough to, when I'm not traveling, wake up next to her and see her at night, and that's the best part. [00:30:08] Lindsey Dinneen: Yeah, absolutely. What a wonderful thing. Well, this has been a fantastic conversation, Garrett. I'm so thankful for your time today. Thank you for sharing some of your stories, some of your advice. And I just honestly wish you the most continued success as you work to change lives for a better world. [00:30:26] Garrett Schumacher: Thank you. Thank you, Lindsey, for having me. This was my first podcast ever. So it went great. Yeah, it was fine. [00:30:32] Lindsey Dinneen: Awesome. You rocked it. Good job. That's wonderful. All right, well, celebrating that and celebrating all your future successes to come. We are so honored to be making a donation on your behalf as a thank you for your time today to Save the Children, which works to end the cycle of poverty by ensuring communities have the resources to provide children with a healthy, educational, and safe environment. So thank you so much for choosing that charity to support, and thank you so much for being here and thank you for doing what you do. [00:31:05] Garrett Schumacher: Thank you. [00:31:07] Lindsey Dinneen: Excellent, and thank you also to our listeners for tuning in, and if you're feeling as inspired as I am, I'd love it if you'd share this episode with a colleague or two and we'll catch you next time. [00:31:19] Dan Purvis: The Leading Difference is brought to you by Velentium Medical. Velentium Medical is a full service CDMO, serving medtech clients worldwide to securely design, manufacture, and test class two and class three medical devices. Velentium Medical's four units include research and development-- pairing electronic and mechanical design, embedded firmware, mobile app development, and cloud systems with the human factor studies and systems engineering necessary to streamline medical device regulatory approval; contract manufacturing-- building medical products at the prototype, clinical, and commercial levels in the US, as well as in low cost regions in 1345 certified and FDA registered Class VII clean rooms; cybersecurity-- generating the 12 cybersecurity design artifacts required for FDA submission; and automated test systems, assuring that every device produced is exactly the same as the device that was approved. Visit VelentiumMedical.com to explore how we can work together to change lives for a better world.

The Nazi dictator is believed to have had a hidden genetic disorder known as Kallmann syndrome, which can thwart the development of sexual organs, according to a stunning new documentary analyzing his biological makeup. Please Like, Comment and Follow 'Philip Teresi on KMJ' on all platforms: --- Philip Teresi on KMJ is available on the KMJNOW app, Apple Podcasts, Spotify, YouTube or wherever else you listen to podcasts. -- Philip Teresi on KMJ Weekdays 2-6 PM Pacific on News/Talk 580 AM & 105.9 FM KMJ | Website | Facebook | Instagram | X | Podcast | Amazon | - Everything KMJ KMJNOW App | Podcasts | Facebook | X | Instagram See omnystudio.com/listener for privacy information.

BUFFALO, NY — November 13, 2025 — A new #research paper was #published in Volume 17, Issue 10 of Aging-US on October 3, 2025, titled “The role of phenylalanine and tyrosine in longevity: a cohort and Mendelian randomization study.” In this study led by Jie V. Zhao, Yitang Sun, Junmeng Zhang, and Kaixiong Ye from the University of Hong Kong and the University of Georgia, researchers investigated whether two amino acids, phenylalanine and tyrosine, affect how long people live (lifespan). The results suggest that higher levels of tyrosine are linked to shorter life expectancy in men, pointing to potential sex-specific approaches to promoting longevity. Phenylalanine and tyrosine are amino acids involved in metabolism and brain function. Both are found in protein-rich foods and dietary supplements, but their long-term effects on aging are not well understood. Tyrosine, in particular, is a building block of neurotransmitters such as dopamine, which regulate mood and cognitive function, making it a molecule of interest in aging research. The study analyzed data from more than 270,000 individuals in the UK Biobank. Using both observational and genetic methods, the researchers examined the associations between blood levels of phenylalanine and tyrosine with overall mortality and predicted lifespan. Although both amino acids were initially linked to higher mortality risk, only tyrosine showed a consistent and potentially causal association with reduced life expectancy in men. Genetic analyses estimated that elevated tyrosine levels could shorten men's lifespan by nearly one year. No significant effect was observed in women. These findings remained consistent even after adjusting for related factors, including the role of phenylalanine. This suggests that tyrosine may independently influence aging. The researchers also observed that men tend to have higher tyrosine levels than women, which could partly explain the gender gap in lifespan. “Phenylalanine showed no association with lifespan in either men or women after controlling for tyrosine.” The exact mechanisms behind this effect are still under investigation. However, tyrosine's involvement in insulin resistance and the production of stress-related neurotransmitters may be contributing factors. Insulin resistance is associated with many age-related diseases, and hormone-related pathways influenced by tyrosine may differ between men and women, potentially explaining the sex-specific outcomes. Although tyrosine is commonly marketed as a supplement for enhancing focus and mental performance, the study raises concerns about its long-term impact on lifespan. While the researchers did not directly study tyrosine supplementation, their findings suggest that people with high tyrosine levels may benefit from dietary adjustments. Strategies such as protein restriction could help reduce tyrosine levels and support healthier aging. Further studies are needed to confirm these findings and explore whether diet and lifestyle changes can safely lower tyrosine levels to promote longevity. DOI - https://doi.org/10.18632/aging.206326 Corresponding author - Jie V. Zhao - janezhao@hku.hk Abstract video - https://www.youtube.com/watch?v=rr0G44TD36M Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alerts To learn more about the journal, please visit https://www.Aging-US.com​​ and connect with us on social media: Facebook - https://www.facebook.com/AgingUS/ X - https://twitter.com/AgingJrnl Instagram - https://www.instagram.com/agingjrnl/ YouTube - https://www.youtube.com/@Aging-US LinkedIn - https://www.linkedin.com/company/aging/ Bluesky - https://bsky.app/profile/aging-us.bsky.social Pinterest - https://www.pinterest.com/AgingUS/ Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc MEDIA@IMPACTJOURNALS.COM

I Thought My High Cholesterol Was Genetic—Until I Went Plant-Based "I had my blood work done the day before I started the transition. My total cholesterol was 298, and my LDL was 174. In the first month of following a WFPB diet, I took 76 points off my total cholesterol and 44 points off my LDL cholesterol. The weight started coming off, and I was all in." Listen to this success story written by Joanna Mittman at forksoverknives #vegan #plantbased #plantbasedbriefing #cholesterol #wfpb ====================== Original post:  https://www.forksoverknives.com/success-stories/i-thought-my-high-cholesterol-was-genetic-until-i-went-plant-based/    Forks Over Knives Documentary: https://www.forksoverknives.com/the-film/  =========================== Forks Over Knives was founded following the release of the world-famous documentary Forks Over Knives in 2011, showing people how to regain control of their health and their lives with a plant-based diet. Since then Forks Over Knives released bestselling books, launched a mobile recipe app and maintains a website filled with the latest research, success stories, recipes, and tools to help people at every phase of their plant-based journeys. They also have a cooking course, a meal planner, a line of food products, and a magazine. Please visit www.ForksOverKnives.com for a wealth of resources.  FOLLOW THE SHOW ON: YouTube: https://www.youtube.com/@plantbasedbriefing     Spotify: https://open.spotify.com/show/2GONW0q2EDJMzqhuwuxdCF?si=2a20c247461d4ad7 Apple Podcasts: https://podcasts.apple.com/us/podcast/plant-based-briefing/id1562925866 Your podcast app of choice: https://pod.link/1562925866  Facebook: https://www.facebook.com/PlantBasedBriefing     LinkedIn: https://www.linkedin.com/company/plant-based-briefing/   Instagram: https://www.instagram.com/plantbasedbriefing/

In this explainer episode, we've asked Amanda Pichini, clinical director at Genomics England and genetic counsellor, to explain what a genetic counsellor is. You can also find a series of short videos explaining some of the common terms you might encounter about genomics on our YouTube channel. If you've got any questions, or have any other topics you'd like us to explain, let us know on podcast@genomicsengland.co.uk. You can download the transcript or read it below. Florence: What is a genetic counsellor? I'm Florence Cornish, and today I'm joined with Amanda Pichini, a registered genetic counsellor and clinical director for Genomics England, to find out more.   So, before we dive in, lots of our listeners have probably already heard the term genetic counsellor before, or some people might have even come across them in their healthcare journeys. But for those who aren't familiar, could you explain what we mean by a genetic counsellor?  Amanda: Genetic counsellors are healthcare professionals who have training in clinical genomic medicine and counselling skills. So they help people understand complex information, make informed decisions, and adapt to the impact of genomics on their health and their family. They're expert communicators, patient advocates, and navigators of the ethical issues that genomics and genomic testing could bring.  Florence: Could you maybe give me an example of when somebody might see a genetic counsellor?   Amanda: Yes, and what's fascinating about genetic counselling is that it's relevant to a huge range of conditions, scenarios, or points in a person's life.  Someone's journey might start by going to their GP with a question about their health. Let's say they're concerned about having a strong family history of cancer or heart disease, or perhaps a genetic cause is already known because it's been found in a family member and they want to know if they've inherited that genetic change as well.   Or someone might already be being seen in a specialist service, perhaps their child has been diagnosed with a rare condition. A genetic counsellor can help that family explore the wide-ranging impacts of a diagnosis on theirs and their child's life, how it affects their wider family, what it might mean for future children. You might also see a genetic counsellor in private health centres or fertility clinics, or if you're involved in a research study too.   Florence: And so, could you explain a bit more about the types of things a genetic counsellor does? What does your day-to-day look like, for example?   Amanda: Most genetic counsellors in the UK work in the NHS as part of a team alongside doctors, lab scientists, nurses, midwives, or other healthcare professionals. Their daily tasks include things like analysing a family history, assessing the chance of a person inheriting or passing on a condition, facilitating genetic tests, communicating results, supporting family communication, and managing the psychological, the emotional, the social, and the ethical impacts of genetic risk or results.   My day-to-day is different though. I and many other genetic counsellors have taken their skills to other roles that aren't necessarily in a clinic or seeing individual patients. It might involve educating other healthcare professionals or trainees, running their own research, developing policies, working in a lab, or a health tech company, or in the charity sector.   For me, as Clinical Director at Genomics England, I bring my clinical expertise and experience working in the NHS to the services and programmes that we run, and that helps to make sure that we design, implement, and evaluate what we do safely, and with the needs of patients, the public, and healthcare professionals at the heart of what we do.    My day-to-day involves working with colleagues in tech, design, operations, ethics, communications, and engagement, as well as clinical and scientific experts, to develop and run services like the Generation Study, which is sequencing the genomes of 100,000 newborn babies to see if we can better diagnose and treat children with rare conditions.  Florence: So, I would imagine that one of the biggest challenges of being a genetic counsellor is helping patients to kind of make sense of the complicated test results or information, but without overwhelming them. So how do you balance kind of giving people the scientific facts and all the information they need, but while still supporting them emotionally?   Amanda: This is really at the core of what genetic counsellors can do best, I think. Getting a diagnosis of a rare condition, or finding out about a risk that has a genetic component, can come with a huge range of emotions, whether that's worry, fear, or hope and relief.  It can bring a lot of questions, too. What will this mean for my future or my family's future? What do you know about this condition? What sort of symptoms could I have? What treatments or screening might be available to me? So genetic counsellors are able to navigate all of these different questions and reactions by giving an opportunity for patients and families to discuss their opinions, their experiences, and really trying to get at the core of understanding their values, their culture, their expectations, their concerns, so that they can help that individual make an informed decision that's best for them, help them access the right care and support, adjust or find healthy coping strategies, or maybe even change their lifestyle or health behaviours. So it's really finding that balance between the science, the clinical aspects, the information, and the support.  Florence: So obviously working in this space, I get to read about lots of incredible research all the time, and it feels like genetics and genomics seems to be changing and advancing day by day. So, I'd be interested to know what this means for you and for other genetic counsellors, what's coming next?   Amanda: Yeah, so as we continue to see advances in genetics and genomics, there's, I think, a really increasing need for genetic counselling expertise to help shape how these technologies are used and with giving the right consideration for the challenges around what this means for families and for wider society.  Genomics is also still growing the evidence base it needs to provide a consistent and equitable service. We're seeing digital tools being increasingly available to give people information in innovative ways, seeing huge advancements in targeted treatments and gene therapies, that are changing fundamentally the experiences of people living with rare conditions and cancers. And we're using genomics more and more to predict future health risks and how people might respond to certain medications. So, there's a huge amount that we're seeing sort of coming for the future.   What's interesting is the 10-Year Health Plan that the government has set out for the NHS provides, I think, huge opportunities for genomics. For example, we'll see healthcare brought closer to local communities, genomics being used as part of population health, reaching people closer to where they are and hopefully providing greater access.   But I think the key thing in all of this is knowing that genomics is really just a technology. It requires people with the right skill sets to use it safely and to be able to benefit everyone, and genetic counsellors are a huge part of that.   Florence: And finally, in case anyone listening has been inspired by this conversation and wants to build a career like yours, what advice would you have to offer somebody hoping to become a genetic counsellor in the future?   Amanda: To train as a genetic counsellor in the UK, you usually need an undergrad degree in biological sciences, psychology, or being a nurse or midwife. The background can be varied, but usually driven by a common thread, a desire to sort of improve healthcare experiences for patients and make genomic healthcare widely accessible and safely used for everyone.  You can apply for the 3-year NHS scientist training programme, or there's also master's degrees offered through Cardiff University, for example. In general, I'd encourage people to check out the website for the Association of Genetic Nurses and Counsellors, and reach out to genetic counsellors to ask about their career and their journey as much as possible, as well as seeking opportunities to really understand the experiences of people living with rare genetic conditions, because that will help you understand the ways in which genetic counselling can have an impact.  Florence: We'll finish there. Thank you so much, Amanda, for all of those insights and for explaining what it means to be a genetic counsellor. If any listeners want to hear more explainer episodes like this, you can find them on our website at www.genomicsengland.co.uk or wherever you get your podcasts.  Thank you for listening. 

Cody Hodgson and The RYR-1 Foundation 11/11/25Diagnosed in 2016 with RYR-1-related malignant hyperthermia, Cody Hodgson's promising NHL playing career was cut short when the effects of his disease made it impossible for him to push his body to the extent necessary in pro hockey. However, what initially looked like a major setback gave way to a very different, equally powerful calling. Now an active ambassador for the Pittsburgh, PA-based RYR-1 Foundation, Hodgson is precisely the kind of figure in the hockey world that our production staff loves connecting with.With mobile recording gear in tow, our producer and co-host, Jeff Taylor recently joined the RYR-1 Foundation in Pittsburgh for their 10th anniversary conference. A handful of in-depth interviews were conducted that day, including with former NHL'er Cody Hodgson himself, as well as Toronto-based anesthesiologist Dr. Sheila Riazi, Hodgson's diagnosing physician. Reading: The RYR-1 Foundation's Clinical Care Guidelines text:https://ryr1.org/clinical-care-guidelinesVideo: Watch Cody Hodgson score an incredible shorthanded goal, beating all five Carolina Hurricanes players:https://www.youtube.com/watch?v=1pyGSyfkO6IVideo: Wim Hof Breathing Method (YouTube):https://www.youtube.com/watch?v=tybOi4hjZFQToday's episode was co-produced by Jeff Taylor and Ashley Taylor.Very special thanks to Espresso A Mano, Pittsburgh's finest coffee roasters and cafe, for partnering with Fly Penguins Fly podcast. Visit an Espresso A Mano location near you:https://espressoamano.com/Thank you for listening!! Follow the podcast on X/Twitter: @penspodJeff Taylor: @penspod_JT // Jordan DeFigio: @fidgenewtonLETS GO PENS.JEFF TAYLOR + JORDAN DEFIGIOFly Penguins Fly Podcast is produced by Jeff TaylorOriginal theme and outro music composed and recorded by Jeff TaylorMark Guiliana played drums, Ashley Taylor sang.Interested in becoming a sponsor of the podcast?Email the Fly Penguins Fly Podcast at: penspod@gmail.comShane Taylor designed and delivered our artwork.Hire Shane: shanetaylordesigns@gmail.comThis episode includes portions of the following musical selections:Fly Penguins Fly Theme composed and produced by Jeff TaylorKid Kodi by Blue Dot SessionsHammers and Tape composed and produced by Jeff TaylorArp Landing composed and produced by Jeff TaylorInside the Paper Crane by Blue Dot SessionsHardboil by Blue Dot SessionsCamphor Kingdom by Blue Dot SessionsDiatom by Blue Dot Sessions

Send us a textIn this episode, Dr. Marina Metzler (St. Louis Children's) shares her experience as a mentored fellow within the CHNC network, focusing on her project investigating genetic diagnoses in neonates with hypoxic-ischemic encephalopathy (HIE). She discusses the application and mentorship process, the support available from statisticians and CHNC collaborators, and early findings showing that infants with genetic conditions often experience longer NICU stays, more ventilator support, and greater feeding challenges. Dr. Metzler highlights the potential for genetic testing to refine diagnosis, guide care, and inform families, while emphasizing the need for larger datasets and multi-center collaboration to advance understanding in this complex population.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

In this episode of Rx for Biotech podcast, I speak with Philippe Chambon MD, PhD, CEO of EG 427, about how his company's HERMES technology platform could improve on the precision, durability and safety of gene therapy delivery. EG 427's lead candidate, EG110A, targets neurogenic bladder - a chronic condition linked to spinal cord injury, Parkinson's disease and multiple sclerosis - using a localized gene therapy designed to restore neuronal control with minimal side effects.

The last in a special QIMR Berghofer Originals 80th Anniversary podcast seriesWhether you're fascinated by genetics, or just love a story with a little serendipity and a lot of grit, the last episode of the QIMR Berghofer Originals podcast series is a masterclass in what it means to push boundaries, build communities and stay curious for a lifetime. Hear how Professor Nick Martin turned twins into a research powerhouse and made Brisbane a hub of genetic discovery.

Migration Routes and Genetic Groups 2. Professor Meltzer details the migration routes of ancestral Native Americans, explaining that while they crossed the land bridge during maximum glaciation, they were initially trapped in Alaska by two vast continental ice sheets. The "ice free corridor" along the Rockies was not a viable route until around 13,000 years ago, so the likely path was down the Pacific coast, which may have cleared as early as 16,500 years ago. Meltzer introduces the concept of a "genetic ghost," which is evidence in the genomic record of a contributing population for which no physical sample has yet been found.

[00:13:27] – Technocracy and the Artificial Womb AgendaKnight examines Sam Altman's biotech ventures creating lab-grown embryos, framing them as tools of population control and evidence of a transhumanist ideology seeking to replace natural reproduction. [00:24:39] – The Epstein Files and Political ObstructionKnight connects Speaker Mike Johnson's refusal to reconvene Congress to the stalled release of Epstein documents, arguing that both parties are complicit in shielding elite criminal networks. [00:49:59] – Trump's Tariff Socialism & Corporate CronyismHe explains how Trump's tariffs operate as hidden taxes that enrich corporations while deepening national debt, turning populism into state-managed corporate welfare. [01:07:42] – Supply Chain Meltdown and Grounded Cargo JetsKnight reports on grounded UPS and FedEx planes and looming shipping disruptions, using the crisis to illustrate how centralized regulation and aging infrastructure are undermining logistics before the holidays. [01:24:51] – Michael Burry's AI Short and the Coming CrashKnight discusses investor Michael Burry's massive short against major AI firms, warning that speculative overvaluation in artificial intelligence mirrors the 2008 financial bubble. [01:39:35] – Smart Appliances and the Surveillance HomeHe contrasts durable mid-century appliances with today's internet-connected “smart” devices, describing them as instruments of data harvesting that turn private homes into nodes of surveillance. [02:06:19] – The AI Arms Race and Energy CrisisKnight warns that the global competition for AI dominance is driving up energy demand and electricity costs, linking the net-zero agenda and AI expansion as dual engines of centralized energy control. [02:08:27] – Sam Altman and the Rise of Genetically Engineered BabiesHe exposes Altman's investments in designer embryo research, suggesting that “biotech humanitarianism” masks a program for eugenic social engineering and artificial reproduction. [02:20:57] – Brain-Reading AI and the End of PrivacyKnight reviews new brain-imaging systems capable of reconstructing thoughts and images, calling them precursors to mind surveillance funded by military and intelligence agencies. [02:51:03] – The Cult of Elon Musk and Robot WorshipKnight concludes with a critique of Musk's AI and robotics showcases, describing them as technological idolatry that promotes dependency, surveillance, and the replacement of human purpose with machines. Money should have intrinsic value AND transactional privacy: Go to https://davidknight.gold/ for great deals on physical gold/silverFor 10% off Gerald Celente's prescient Trends Journal, go to https://trendsjournal.com/ and enter the code KNIGHTFind out more about the show and where you can watch it at TheDavidKnightShow.com If you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-showOr you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7Become a supporter of this podcast: https://www.spreaker.com/podcast/the-david-knight-show--2653468/support.

The Man Behind Cannabis Tissue Culture Labs

Welcome to the ninety-second episode of Through A Glass Darkly Radio with Sean Patrick Hazlett! For this episode, we will discuss the strange paradoxes associated with Mantid beings. Do not miss this amazing episode! Intro: "Mark of the Doomslayer" by Karl Casey @ White Bat Audio Copyright © 2025 Through a Glass Darkly Radio with Sean Patrick Hazlett. All rights reserved.

In this episode, Dr. Puder is joined by Dr. Liam Browning and Dr. Nicholas Fabiano to explore the complex genetic and environmental factors that contribute to schizophrenia. They unpack how heritability is measured, what twin and genome-wide association studies reveal, and why the "missing heritability" problem matters for our understanding of mental illness. The discussion also covers how prenatal factors, childhood trauma, cannabis use, and social adversity increase risk and how modern neuroscience reframes schizophrenia as a disorder of brain connectivity rather than a single genetic disease.

Could the root cause of chronic diseases like type 2 diabetes, heart disease, and hypertension really be the same? In this video, I'll show you how to prevent chronic illness by effectively addressing the root cause, rather than just the symptom. “Based on my genetic report, identify which genes show adaptations to ancestral diets (hunter-gatherer, farming, natural). Then, explain how these same genes may create a mismatch with modern diets and environments. For each, show practical consequences and strategies to thrive today.”0:00 Introduction: The #1 root cause of chronic disease 0:20 Medicine ignores the root cause of health problems 1:23 What causes chronic disease?4:45 Genetics and chronic disease10:16 Tips for chronic disease preventionMedicine aims to label a disease and treat the symptoms with medication. Medication comes with side effects, which are then treated with more medication. Focusing on the root cause of health problems could help avoid numerous issues. The average adult consumes over 50% of their calories from ultra-processed foods. Food is readily available, we're constantly looking at screens, and we're exposed to toxins like never before. Sterilized food and environments have caused underdeveloped immune systems and epidemic-level nutrient deficiencies. Genetics plays a role in disease and immunity, but there's more to it. Genetics can provide clues about potential health issues we may encounter if our diet and environment are not quite right. Disclaimer from 3X4 Genetics: Data privacy is of utmost importance to us. We handle your personal information with the highest standards of rigor and integrity; our practices, procedures, policies, and technology are designed to ensure the security of your privacy and health data. Upon release of your report, it is your discretion and responsibility to determine with whom or which platform you share or upload your genetic results report to.Dr. Eric Berg DC Bio:Dr. Berg, age 60, is a chiropractor who specializes in Healthy Ketosis & Intermittent Fasting. He is the Director of Dr. Berg Nutritionals and author of the best-selling book The Healthy Keto Plan. He no longer practices, but focuses on health education through social media.Disclaimer: Dr. Eric Berg received his Doctor of Chiropractic degree from Palmer College of Chiropractic in 1988. His use of “doctor” or “Dr.” in relation to himself solely refers to that degree. Dr. Berg is a licensed chiropractor in Virginia, California, and Louisiana, but he no longer practices chiropractic in any state and does not see patients, so he can focus on educating people as a full-time activity, yet he maintains an active license. This video is for general informational purposes only. It should not be used to self-diagnose, and it is not a substitute for a medical exam, cure, treatment, diagnosis, prescription, or recommendation. It does not create a doctor-patient relationship between Dr. Berg and you. You should not make any change in your health regimen or diet before first consulting a physician and obtaining a medical exam, diagnosis, and recommendation. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition.

For the first time in human history, we can diagnose thousands of genetic diseases—often for under $1,000—but we still can't treat most of them. The problem isn't understanding what's broken; it's delivering the fix to the right cells.Eric Kelsic, CEO of Dyno Therapeutics, joins a16z's Jorge Conde to explain how AI-designed protein shells are solving gene therapy's delivery crisis. They explore why Huntington's patients can now get 15 extra years of healthy life, how Dyno inverted the liver-to-brain delivery ratio by 1000x, and why capsids evolved by nature are now being designed by machine learning models trained on millions of variants.Eric introduces the concept of genetic agency—humanity's first-ever ability to take action at the DNA level—and details why solving delivery for common diseases will make ultra-rare disease treatments economically viable. Plus: what happens when gene therapy requires neurosurgery today but could be a simple injection tomorrow, why recent deaths in clinical trials prove we need better technology now, and how genetic medicine could become as routine as surgery within our lifetimes. Resources:Follow Eric on X: https://x.com/ekelsicFollow Jorge on X: https://x.com/JorgeCondeBioLearn more about GATC 2025: https://www.dynotx.com/gatc2025 Stay Updated:If you enjoyed this episode, be sure to like, subscribe, and share with your friends!Find a16z on X: https://x.com/a16zFind a16z on LinkedIn: https://www.linkedin.com/company/a16zListen to the a16z Podcast on Spotify: https://open.spotify.com/show/5bC65RDvs3oxnLyqqvkUYXListen to the a16z Podcast on Apple Podcasts: https://podcasts.apple.com/us/podcast/a16z-podcast/id842818711Follow our host: https://x.com/eriktorenbergPlease note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Welcome back for another dose of the Refill! Bringing you the latest insights and news in the world of mental health and pharmacy. If you want more tips and conversations about mindfulness, and mental health checkout The Mindful PharmD Podcast on major podcast platforms. Music provide by PodcastleWritten by Dr. Matmon Harrell ReferencesSalam, N. (2025, October 23). Generic statin atorvastatin recalled. USA Today. https://www.usatoday.com/story/money/2025/10/23/generic-statin-atorvastatin-calcium-recall/86861216007/H. (2025, October 24). FDA announces nationwide recall of cholesterol medication—More than 140,000 bottles affected. Health. https://www.health.com/atorvastatin-calcium-recall-october-2025-11837002 Unknown Author. (n.d.). Genetic marker identifies responders to new antidepressant. Psychology Today. https://www.psychologytoday.com/us/blog/demystifying-psychiatry/202510/genetic-marker-identifies-responders-to-new-antidepressantDucharme, J. (2025, October 20). Brain game boosts chemical linked to memory, dementia research shows. NBC News. https://www.nbcnews.com/health/aging/brain-game-boosts-chemical-memory-dementia-research-rcna237832Subscribe. Share. Rate.A thousand thanks!drmatmonharrell.bio.link Hosted on Acast. See acast.com/privacy for more information.

Austin Gravley of Digital Babylon and the What Would Jesus Tech podcast talks about how the Chinese Communist Party is looking at using AI to enhance the genetic "quality" of their children, among other uses.  What are the ethical guidelines?  What are acceptable and unacceptable uses?  The National Day of Prayer Taskforce's Kathy Branzell (who is a "military brat") talks about the importance of supporting and praying for our veterans and current military members.  The also talks about giving thanks and "telling of His glory among the nations, Hsi wonderful deeds among all the peoples."  Faith Radio podcasts are made possible by your support. Give now: Click here  

Paula Jardine discusses her research into the biodefense mafia or bio-security cabal and their decades-long machinations to impose a global dystopia based on genetic testing and engineering and digital control. She says planning goes as far back as the Project for a New American Century (PNAC) and beyond, and is alarmed that one of the key operators, Robert Kadlec, is being considered for a new position in the Department of War. Watch on BitChute / Brighteon / Rumble / Substack / YouTube *Support Geopolitics & Empire! Become a Member https://geopoliticsandempire.substack.com Donate https://geopoliticsandempire.com/donations Consult https://geopoliticsandempire.com/consultation **Visit Our Affiliates & Sponsors! Above Phone https://abovephone.com/?above=geopolitics easyDNS (15% off with GEOPOLITICS) https://easydns.com Escape The Technocracy (15% off with GEOPOLITICS) https://escapethetechnocracy.com/geopolitics Outbound Mexico https://outboundmx.com PassVult https://passvult.com Sociatates Civis https://societates-civis.com StartMail https://www.startmail.com/partner/?ref=ngu4nzr Wise Wolf Gold https://www.wolfpack.gold/?ref=geopolitics Websites X https://x.com/PaulaJardine The Conservative Woman https://www.conservativewoman.co.uk/author/paulajardine Brownstone https://brownstone.org/author/paula-jardine About Paula Jardine Paula Jardine is a writer/researcher who has just completed the graduate diploma in law at ULaw. She has a history degree from the University of Toronto and a journalism degree from the University of King's College in Halifax, Nova Scotia. *Podcast intro music is from the song "The Queens Jig" by "Musicke & Mirth" from their album "Music for Two Lyra Viols": http://musicke-mirth.de/en/recordings.html (available on iTunes or Amazon)

In this episode of Two Bees in a Podcast, Amy Vu and Dr. Jamie Ellis speak with Dylan Ryals, a Doctoral Candidate in the Entomology Department at Purdue University, about implementing genetic sequencing analysis to select breeding candidates in an apiary. This episode ends with a Q&A segment. Check out our website: www.ufhoneybee.com for additional resources from today's episode.

We've entered a new age. Where nature once took a million years to make a few genetic changes, scientists can now make billions in an afternoon — and even imagine adapting humans for life beyond Earth.George Church, a Harvard geneticist, pioneer of the Human Genome Project, and founder of more than 50 biotech companies, helped lay the foundation for CRISPR, personal genomics, and even de-extinction.In this episode, he explains how biotechnology, AI, and materials science are converging to transform life itself -  from reversing aging and curing disease to resurrecting lost species like the woolly mammoth, and one day, helping humanity thrive among the stars.

Welcome to E426 of Inner Voice: A Heartfelt Chat with Dr. Foojan, In this episode, Dr. Foojan Zeine, psychotherapist, author, and founder of the Awareness Integration Institute, has a deeply insightful conversation with Dr. Rogers Follansbee, philosopher and clinical psychologist. Together, they explore Structured Psychology Theory, the foundation of Relational Existence, and the true meaning behind projection, free will, and human behavior — revealing how our relationships shape who we are and how we experience the world.

We continue our wedding series with Star Trek: The Next Generation's "Haven" -- in which Deanna Troi's arranged marriage is interrupted by the arrival of an AIDS allegory. It's … rough. It's rough.  Note: Liz says two completely inaccurate things with absolute confidence: first she claims that Wyatt is the only guest star with a costume change (false, that is Lwaxana) and then she claims that he's wearing grey in the holodeck scene (he is wearing burgundy). And unfortunately these were LOAD-BEARING INACCURACIES that couldn't easily be edited out. Never trust a podcaster.  "I don't know who wrote this, but I cannot support them."  We know early TNG loved a Special Boy, but why is Wyatt Miller the protagonist of this episode?  Is Lwaxana Troi a reliable source of information on Betazoid culture and custom?  "Genetic bonding" is a fancy word for "child betrothal" and also sounds kiiiiiiiinda sketchy? Were Ian Troi and the Millers attempting to pull some sort of eugenics shenanigans? (Streaming movie about Michelle Yeoh taking out Ian Troi, co-starring Jess Bush as young Lwaxana, when?) Liz is not a fan of Lwaxana and takes issue with the current "if you don't like Lwaxana Troi, you're a misogynist" discourse "I would like to have a dinner party with Lwaxana Troi and Cersei Lannister."  Is Mon Mothma the anti-Lwaxana Troi? Either way, she's joining Lwaxana and Cersei for cocktails

Dr. Matt Goldstein, CEO of jscreen, focuses on the importance and power of preventive genetic testing for reproductive carrier screening and hereditary cancer screening. All genetic tests include analysis to inform specific medical management plans and provide genetic counselors to explore options. Of particular interest is testing for the gene mutations that cause Tay-Sachs disease and helping families take proactive steps to effectively eliminate the disease in future generations. Matt explains, "So, jscreen is a nonprofit that focuses on providing access to education and high-touch support to individuals, families, and to clinicians in the area of preventive genetics and more specifically for reproductive carrier screening and hereditary cancer screening. "These types of tests actually have been around for a really long time with the advancement in genomic technology and our knowledge generally of genetics. The capabilities we have around these panels—what we can test for and what we can do with them—have grown tremendously over the last two decades. And so, what we're offering now is completely different than what you may have been offered five or 10 years ago." "What I will say is I think that this technology is the most powerful medical intervention that we have. Maybe second to vaccines, which we know obviously can have profound impacts on saving lives, preventive genetics, the ability to screen an individual or a couple or a family, and identify diseases that they may be at risk for, with things that you can do to prevent those diseases from happening or catch them early. That's the holy grail. That's the most amazing thing: being able to intervene."  #jscreen #GeneticTesting #TaySachsDisease #ReproductiveCarrierScreening #HereditaryCancerScreening  jscreen.org Download the transcript here

Dr. Matt Goldstein, CEO of jscreen, focuses on the importance and power of preventive genetic testing for reproductive carrier screening and hereditary cancer screening. All genetic tests include analysis to inform specific medical management plans and provide genetic counselors to explore options. Of particular interest is testing for the gene mutations that cause Tay-Sachs disease and helping families take proactive steps to effectively eliminate the disease in future generations. Matt explains, "So, jscreen is a nonprofit that focuses on providing access to education and high-touch support to individuals, families, and to clinicians in the area of preventive genetics and more specifically for reproductive carrier screening and hereditary cancer screening. "These types of tests actually have been around for a really long time with the advancement in genomic technology and our knowledge generally of genetics. The capabilities we have around these panels—what we can test for and what we can do with them—have grown tremendously over the last two decades. And so, what we're offering now is completely different than what you may have been offered five or 10 years ago." "What I will say is I think that this technology is the most powerful medical intervention that we have. Maybe second to vaccines, which we know obviously can have profound impacts on saving lives, preventive genetics, the ability to screen an individual or a couple or a family, and identify diseases that they may be at risk for, with things that you can do to prevent those diseases from happening or catch them early. That's the holy grail. That's the most amazing thing: being able to intervene."  #jscreen #GeneticTesting #TaySachsDisease #ReproductiveCarrierScreening #HereditaryCancerScreening  jscreen.org Listen to the podcast here

Which communities bear the brunt of pollution during pregnancy and early life? Woodruff explores the links between socioeconomic status, genetics, and environmental exposure, illustrating how 'double jeopardy' and environmental injustice compound health risks for vulnerable families. Timestamps: 01:36 – Pre-term birth 06:07 – Gut microbiome 11:37 – Genetic factors 12:59 – Double jeopardy   14:26 – Environmental injustice  14:54 – Cancer valley 

Vidcast:  https://www.instagram.com/p/DQdnYr9jZwV/An exciting, ground-breaking clinical study now shows that children born with a defective gene coding for a vital inner ear protein can have that gene  repaired and hearing restored. This phenomenally successful preliminary clinical trial was recently published in the New England Journal of Medicine.Genetic bioengineers at New York's Regeneron Pharmaceuticals loaded a normal copy of the otoferlin gene into a dual adeno-associated virus acting as a Trojan horse.  Twelve children, born without the ability to synthesize otoferlin protein, received the gene injection, dubbed DB-OTO therapy, into their inner ears at 3 clinical centers: Harvard's Mass. Eye and Ear Infirmary, UC San Diego's Children's Hospital, and University College London.  Otoferlin is necessary for the inner ear's ability to convert sound vibrations into electrical impulses.  At 24 weeks post-injection, 9 of the 12 children, 75%, regained measurable hearing.  Three, 25%, developed near normal hearing.  The gene therapy was well-tolerated without any significant side effects.This gene therapy, with further refinement and after larger clinical trials, may be a one-and-done treatment for one common form of congenital deafness. Cochlear implants will continue to be essential therapy for other types of genetic and acquired severe hearing losses pending development of other genetic and/or chemical cochlear modifications.https://www.nejm.org/doi/full/10.1056/NEJMoa2400521#deafness #children #congenital #otoferlin #dboto 

The conversation delves into the significance of genetic testing, particularly in relation to conditions like ADHD and ASD. It highlights the broad spectrum of symptoms and issues that can arise, emphasizing the importance of awareness and understanding of these genetic factors.TakeawaysUnless you've done a test, you probably wouldn't know.Signs of ADHD and ASD include memory and learning disabilities.Digestive problems can be linked to genetic issues.Autoimmune issues may arise from genetic factors.Anxiety and depression are common in affected individuals.The impact on the mind can be massive.Genetic testing can reveal hidden conditions.Awareness of these conditions is crucial for parents.Research shows a broad range of related symptoms.Understanding genetics can lead to better management strategies.Genetic testing, ADHD, ASD, autism, memory disabilities, learning disabilities, digestive problems, autoimmune issues, anxiety, depression,  adults with dyslexia, support for adults.Join the clubrightbrainresetters.comGet 20% off your first orderhttps://addednutrition.comIf you want to find out more visit:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠truthaboutdyslexia.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Join our Facebook Group⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠facebook.com/groups/adultdyslexia⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Join The Reality Revolution Tribe

In this episode of SHE MD Podcast, Katie Thurston, former star of season 17 of The Bachelorette, sits down with Mary Alice Haney and Dr.Thaïs Aliabadi to discuss fertility, breast cancer, and navigating life as a public figure. They explore Katie's journey from the Bachelorette, her stage 4 breast cancer diagnosis, fertility preservation, and strategies to maintain confidence and resilience. Listen to gain guidance on self-advocacy, genetic testing, and building supportive communities while taking control of their health journey. This episode delivers hope, practical advice, and inspiration, empowering listeners to prioritize their wellness, advocate for their care, and embrace life fully, even in the face of serious health challenges.Subscribe to SHE MD Podcast for expert tips on PCOS, Endometriosis, fertility, and hormonal balance. Share with friends and visit SHE MD website and Ovii for research-backed resources, holistic health strategies, and expert guidance on women's health and well-being.Sponsors:Mirena - To learn more, visit mirena.com and ask your provider if Mirena could be an option for you. To view the full prescribing information, visit mirena.com/piRocket Money - Cancel your unwanted subscriptions and reach your financial goals faster with Rocket Money. Go to rocketmoney.com/shemd today.Peloton - Let yourself run, lift, sculpt, push, and go. Explore the new Peloton Cross Training Tread+ at onepeloton.comDavid's Protein - David is giving my listeners an exclusive offer – buy four cartons and get the fifth free at davidprotein.com/shemdCymbiotika - Go to Cymbiotika.com/Shemd for 20% off plus free shippingGet Joy - As a listener of SheMD, you'll get 50% off your first subscription order of Get Joy's Freeze Dried Raw Dog Food plus two exclusive gifts: a free scoop and a 4oz bag of treats. Shop getjoyfood.com/shemd to support your dog's gut health and overall wellnessWhat You'll Learn How Katie Thurston navigated fertility preservation and freezing eggs Strategies for managing stage 4 breast cancer with optimism and resilience The importance of genetic testing and early breast cancer detection Building supportive communities and advocating for your own healthKey Timestamps (00:00) Introduction with Katie Thurston, Mary Alice Haney, and Dr. Thaïs Aliabadi (04:03) Katie's journey navigating a cancer diagnosis and her personal life (05:15) Early cancer diagnosis, fertility preservation, and freezing eggs (13:10) Navigating treatment, clinical trials, and holistic wellness approaches (19:30) History of family cancer and genetic testing (29:00) Journey to starring on The Bachorlette (34:30) Online dating, relationships, and finding love while managing health (39:54) Daily life of treatment, including Lupron injections, scans, and managing side effects (47:00) Advocacy, the Booby Broadcast, and educating others on breast health and genetic testing (53:30) Reflecting on confidence, personal growth, and lessons from public life (57:35) Episode wrap-up, actionable advice for listeners, and resourcesKey Takeaways Fertility preservation and proactive health decisions empower long-term wellness Building strong support systems helps navigate the emotional toll of cancer Genetic testing and early detection are critical for personalized care Confidence and self-advocacy improve outcomes and mental health Publicly sharing your journey can inspire, educate, and save livesGuest BioKatie Thurston first appeared on television in 2020 on The Bachelor before stepping into the spotlight as The Bachelorette. Ultimately finding love on her own terms, she married comedian Jeff Arcuri, and together they now reside in New York City. Shortly after her move, Katie was diagnosed with stage IV breast cancer—a journey she now shares openly to raise awareness and empower others to advocate for their health.Links Instagram: https://www.instagram.com/thekatiethurston/Resources MentionedWisdom Panel – Free genetic testing for personalized breast cancer screening and prevention strategies https://www.thewisdomstudy.org/Booby Broadcast – Katie Thurston's community for breast cancer support on Instagram https://www.instagram.com/thekatiethurston/Nodal – Online platform for matching surrogates and intended parents https://www.nodal.com/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Black History Month Special (Part 2) AI - The Truth Exposed! The Black Spy Podcast 216, Season 22, Episode 0007   This week, host Carlton King continues his headfirst dive into the meaning of Black History Month — asking seemingly none provocative questions of Chat GPT such as Why do you and other LLM continue to use terms such as the Middle East” and why does this matter? Carlton argues that while race is a biological nonsense, it remains a powerful political reality shaping lives, identity, and history itself. To illustrate this, Carlton explores the true financial and political objectives and consequences of the British Empire, including how Britain came to rule world finances. Carlton also uncovers how AI is finally challenging a racist, euro-centric manipulation of history with true and evidenced fact, yet strangely Carlton notes that these answers are not provided questionaries in the first instance and he wants to establish why?. Carlton examines who decides who's “Black” and who's “White,” and how these definitions have been weaponised throughout history to dumb down Africa and it's diaspora's real historical legacy. Once again we hope you enjoy this week's episode and learn from it. So, please don't forget to subscribe to the Black Spy Podcast for free, so you never miss another fascinating episode.

Welcome to Season 2 of the Orthobullets Podcast.In this episode, we review the high-yield topic of ⁠Genetic Pearls⁠⁠ from the Basic Science section.⁠Follow ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Orthobullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on Social Media:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube

In this special live episode of the SHE MD Podcast, Olivia Munn joins Dr. Thaïs Aliabadi, Mary Alice Haney, Dr. Shari Goldfarb, and Kristen Dahlgren, for a powerful Breast Cancer Awareness Month panel in New York City. The event coincided with NBC's Today Show coverage and the lighting of the Empire State Building in pink — marking the launch of a national conversation around early detection, AI, and prevention.Together, they explore how lifetime risk assessments, dense breast screening, and AI mammogram prediction tools like Clarity Breast are transforming breast health. The panel also discusses cancer vaccine research, genetic testing, and the importance of women knowing their individual risk scores.Listeners will hear Olivia's personal story of early detection after a high-risk score prompted further imaging, leading to her diagnosis and recovery. This episode offers clarity, action, and hope — empowering every listener to become their own health advocate and partner with their medical team.Subscribe to SHE MD Podcast for expert tips on PCOS, Endometriosis, fertility, and hormonal balance. Share with friends and visit the SHE MD website and Ovii for research-backed resources, holistic health strategies, and expert guidance on women's health and well-being.What You'll LearnHow lifetime risk assessment tools can identify breast cancer risk before symptoms appearWhy dense breast tissue requires supplemental screening beyond mammogramsHow AI predictive tools like Clarity Breast are revolutionizing early detectionThe promise of vaccine research and genetic testing in future breast cancer preventionKey Timestamps(00:00) Live event intro and Breast Cancer Awareness Month context(03:30) Olivia's story: risk score, MRI findings, and early diagnosis(13:00) Dr. Aliabadi and Dr. Goldfarb on dense breast screening and AI tools(16:00) Cancer vaccine and immunotherapy discussion with Kristen Dahlgren(27:00) Genetic testing and family history: understanding your risk(34:00) Audience Q&A: emotional recovery and advocacy(42:00) Is there support for young women being diagnosed with breast cancer?(51:30) Clarifying the term Risk AssessmentKey TakeawaysEvery woman should know her lifetime breast cancer risk scoreDense breasts may obscure cancers — MRI and ultrasound can save livesAI mammogram tools are changing detection from reactive to predictiveResearch into cancer vaccines offers hope for prevention and recurrence reductionAdvocacy and awareness remain key — early action leads to better outcomesGuest BiosOlivia MunnOlivia Munn is an actress, health advocate, and breast cancer survivor. After receiving a high lifetime risk assessment score, she underwent further imaging that revealed cancer across multiple quadrants, leading to a bilateral mastectomy. Since publicly sharing her diagnosis in 2024, she has dedicated her platform toward raising awareness about early detection, risk assessment, and empowering women with knowledge about their breast health.Dr. Shari Goldfarb, MDDr. Shari Goldfarb is a breast medical oncologist at Memorial Sloan Kettering, with a clinical focus on early and advanced breast cancer. Her research centers on survivorship, symptom management, fertility, sexual health, and quality of life for breast cancer patients. She participates in clinical trials aimed at improving outcomes for women during and after treatment.Kristen DahlgrenKristen Dahlgren is a former NBC correspondent who, after her own stage 2 breast cancer diagnosis, left journalism to found the Cancer Vaccine Coalition. She collaborates with top cancer centers to accelerate immunotherapy and vaccine development in breast cancer and advocates for preventive strategies beyond current standards.LinksOlivia Munn – https://www.instagram.com/oliviamunnDr. Shari Goldfarb – https://www.mskcc.org/profile/shari-goldfarbKristen Dahlgren – https://www.linkedin.com/in/kristen-dahlgren-886519292/Donna McKay – https://www.bcrf.org/teamResources MentionedBreast Cancer Research Foundation (BCRF) – Funding for innovative breast cancer research and prevention programs

Arguably one of our absolute favorite podcasts EVER. This preview is rich in history, content, knowledge, and entertainment. The Waldrip Bro's are no slouches in the show calf industry, and they sure offered their best take on every lot in this sale. Now, the coolest thing about this episode is that we have all three brothers on here, including Mr. Jagger Horn. However, a lot of talking can happen, and we know this is a lengthy episode, BUT we promise it's very much worth your time! Get in while you can and enjoy the ride!Empowerment Is Here.Sale Link: https://www.sconlinesales.com/Bids/AuctionsListing/44703

Thank you for tuning in for another episode of Life's Best Medicine. Theresa Lyons, MS, MS, PhD is a Yale University trained scientist, medical strategist, and autism parent. Theresa combines the rigor of a Yale-trained scientist with the compassion of a dedicated mom to transform how we understand autism. Through her research and coaching, she explores the metabolic and nutritional roots of neurological health.   In this episode, Dr. Brian and Theresa talk about… (00:00) Intro (04:27) Theresa's background and why she chose to pursue autism research (09:15) The beginning ofTheresa's autism reversal journey (15:53) Autism diagnosis criteria (17:50) Whether or not the reported increase in autism cases is accurate (20:42) What the big, root cause factors are for autism (23:58) Diet and autism (25:56) Low-hanging fruit treatments for people with autism (29:40) Toxin build-up and autism (31:24) B-9 and Leucovorin (38:22) Genetic autism risk (40:18) Diabetes and other co-morbidities associated with autism (41:32) The keto and carnivore diets for people with autism (43:59) Hydration and autism (46:33) GI health and cognitive health (54:17) Outro   For more information, please see the links below. Thank you for listening!   Links:   Theresa Lyons: Navigating AWEtism: https://awetism.net YouTube: https://www.youtube.com/@navigatingawetism IG: https://www.instagram.com/navigating_awetism/?hl=en   Dr. Brian Lenzkes:  Arizona Metabolic Health: https://arizonametabolichealth.com/ Low Carb MD Podcast: https://www.lowcarbmd.com/ Brain Bootcamp: https://prescott-now.com/event/brain-bootcamp-resource-event/   HLTH Code: HLTH Code Promo Code: METHEALTH • • HLTH Code Website: https://gethlth.com

The fellas sat down with former NFL long snapper, Vanderbilt grad, PhD candidate, and full-time force of nature, Andrew East. Dave kicks things off by recounting his extremely awkward cornhole tournament experience, a moment of social anxiety where he suddenly found himself in a new "gauntlet" of gigantic, ripped athletes.Andrew then dives deep into the absurdity of competing on Special Forces: World's Toughest Test alongside his Olympic gold medalist wife, Shawn Johnson. He reveals the terror of backing out of shrinking tunnels and the grueling 15-hour interrogation where they were put in stress positions while listening to "pigs getting slaughtered."Andrew shares why the zero-to-one jump was the hardest identity shift, leading him and Shawn to intensive counseling after having their third child. Plus, hear Andrew's "free-range parenting" philosophy and why elite athletes often adopt a "relaxed posture" toward sports. It's a rollercoaster ride from awkward cornhole to the torture chamber! Wanna advertise? ⁠Click here Join us: http://dadville.substack.com Shopify - Sign up for your one-dollar-per-month trial and start selling today at ⁠⁠http://shopify.com/dadville⁠⁠ Quince - Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠http://quince.com/dadville⁠ for⁠⁠⁠⁠⁠⁠⁠⁠ 365-day returns, plus free shipping on your order! The Road to Kaeluma - Visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠http://jesusfilm.org/kaeluma-dadville⁠⁠⁠⁠⁠⁠⁠⁠⁠ to listen, learn more, or access discussion guides and other bonus content! Boll & Branch - Get 15% off plus free shipping on your first set of sheets at ⁠⁠⁠⁠⁠http://bollandbranch.com/dadville⁠⁠⁠⁠⁠ Exclusions apply. Learn more about your ad choices. Visit megaphone.fm/adchoices

Purchase on Bookshop: https://bit.ly/43o4Rl3Share, rate, & review the podcast, and follow Zibby on Instagram @zibbyowens!** Follow @totallybookedwithzibby on Instagram for listening guides and more. **(Music by Morning Moon Music. Sound editing by TexturesSound. To inquire about advertising, please contact allie.gallo@acast.com.) Hosted on Acast. See acast.com/privacy for more information.

Dr. Neil deGrasse Tyson is an astrophysicist, author, and science communicator known for making complex cosmic concepts accessible to the public. He serves as the director of the Hayden Planetarium at the American Museum of Natural History in New York City. Through his books, television appearances, and the podcast StarTalk, Dr. Tyson inspires curiosity about the universe and promotes scientific literacy worldwide. His engaging storytelling and wit have made him one of the most recognizable voices in modern science.In our conversation we discuss:(01:08) Mysteries that keep Neil deGrasse Tyson up at night(03:47) How scientists learn to ask the right questions(07:14) Philosophy's role and value in modern science(10:43) Why philosophers stopped influencing physical sciences(12:54) Misinterpretations of Neil's comments on philosophy(17:03) Becoming famous and public accountability(21:07) How scientists stay connected and exchange ideas(24:51) Choosing between teaching, science, and public outreach(28:14) Current research interests and unsolved astrophysics questions(30:43) Impact of private space travel on science(35:16) Relationship between science, politics, and the military(36:30) Why Elon Musk won't reach Mars first(37:49) Future of space tourism and affordability(41:00) Expanding human presence across the solar system(47:35) Genetic engineering, ethics, and human evolution(49:27) Global cooperation and genetic regulation challenges(52:29) Human–AI integration and Neuralink skepticism(55:01) Future of robots and human labor(58:07) Early AI history and the Turing test(1:02:21) Skills young people need in the AI era(1:04:09) Teaching curiosity and lifelong learning(1:07:04) How Neil developed communication and teaching skills(1:09:37) Creating meaning and purpose in life(1:11:01) How Neil wants to be remembered(1:12:53) StarTalk, books, and inspiring public curiosityLearn more about Dr. Neil:https://en.wikipedia.org/wiki/Neil_deGrasse_TysonWatch full episodes on: https://www.youtube.com/@seankimConnect on IG: https://instagram.com/heyseankim

    In this episode of the Angus Underground Podcast, host David Brown and guests Jim McWilliam and Colonel Dave Mullins discuss the Montana Ranch Female Sale and the importance of embracing uniqueness in cattle breeding. They explore innovative approaches to ranching, adapting to environmental challenges, and the significance of customer feedback in shaping breeding programs. The conversation emphasizes the need for intentionality in breeding decisions and the role of genetics in producing high-quality cattle. The episode concludes with reflections on the journey of cattle breeding and the importance of community in the industry. Takeaways·      Embrace uniqueness in cattle breeding.·      Quality is more important than quantity.·      Listen to customer feedback for improvement.·      Adapt breeding practices to environmental challenges.·      Innovation is essential in the cattle industry.·      Intentionality in breeding decisions leads to success.·      Genetic consistency is key to profitability.·      Networking and community are vital in ranching.·      Dare to think outside the box.·      Problem-solving should be at the forefront of breeding strategies.  Chapters00:00 Introduction to Angus Underground Podcast02:24 Excitement for the Upcoming Female Sale09:50 Dare to be Different: Embracing Uniqueness12:36 Innovative Approaches in Cattle Breeding19:49 Adapting to Environmental Challenges29:35 The Importance of Customer Feedback39:42 Genetic Considerations in Cattle Breeding47:33 Conclusion and Reflections on the Journey Learn more about our sponsor, Montana Ranch, by visiting MontanaRanchAngus.com.

Can medications like Ozempic and Mounjaro actually do more than help you lose weight? This minisode features highlights from our full conversation, which premiered October 7th, 2025. Watch the full episode here → https://youtu.be/AcVIiy201H4?si=nlaFL3JnoZHxQVFh Dr. Rocio Salas-Whalen and I explore the difference between GLP-1, GIP, and triple-agonist drugs — and what's next in obesity medicine, how estrogen changes after 40 drive midsection weight gain and inflammation, why GLP-1s reduce cancer and Alzheimer's risk through anti-inflammatory and neuroprotective effects and how obesity and insulin resistance impact fertility and PCOS — and how GLP-1s can help.If you've ever wondered whether GLP-1s are just “weight loss shots” or a real step forward in metabolic and brain health — this “minisode” is a must-listen. *** Follow Dr. Salas-Whalen: Instagram: @drsalaswhalen TikTok: @drsalaswhalen @strengthmd @thedryrevolution *** I'm Louisa Nicola — clinical neuroscientist — Alzheimer's prevention specialist — founder of Neuro Athletics. My mission is to translate cutting-edge neuroscience into actionable strategies for cognitive longevity, peak performance, and brain disease prevention. If you're committed to optimizing your brain — reducing Alzheimer's risk — and staying mentally sharp for life, you're in the right place. Stay sharp. Stay informed. Join thousands who subscribe to the Neuro Athletics Newsletter → https://bit.ly/3ewI5P0 Instagram: https://www.instagram.com/louisanicola_/ Twitter : https://twitter.com/louisanicola_ Topics discussed: 00:00 – Intro 00:04  – The Probiotic GLP-1 Myth 00:19 – The “iPhone Evolution” of GLP-1 Drugs 00:52 – GLP-1 vs GIP vs Triple Agonists Explained 01:24 – Phase 3 Results & Massive Weight Loss Outcomes 01:38 – The Role of Glucagon in Weight Loss 01:56 – Menopause, Estrogen & Midlife Weight Gain0 3:06 – The “Fat Shift” After 40 04:01 – Can You Combine HRT and GLP-1s? 06:17 – “Willpower” vs Biology in Obesity 07:49 – The Genetic and Hereditary Roots of Obesity 08:57 – Breaking the Transgenerational Cycle 09:30 – Thyroid Cancer Myths and GLP-1 Safety 10:49 – GLP-1s and Breast Cancer Prevention 12:06 – Inflammation as the Root of Disease 12:28 – Neuroprotection and Alzheimer's Prevention 13:17 – GLP-1s, PCOS & Fertility Benefits 13:53 – The Positive Ripple Effect on Mental Health 14:21 – GLP-1s Reduce Alzheimer's Risk by 33% 14:58 – The Future of Metabolic Health Learn more about your ad choices. Visit megaphone.fm/adchoices

On this episode, I sit down with Dr. Sasha Hakman, a double board-certified OB-GYN and reproductive endocrinologist at HRC Fertility in Beverly Hills. Dr. Hakman is one of the few specialists in the world offering needle-free IVF, and she brings both expertise and empathy to the conversation around fertility, conception, and women's health.We cover the science and lifestyle factors that impact fertility, including nutrition, exercise, hormone balance, and stress. Dr. Hakman breaks down common myths about fertility, explains what genetic testing can reveal, and shares practical ways to optimize your natural fertility before turning to assisted reproductive technologies. She also gives insight into how metabolic and genetic aging influence egg quality and pregnancy outcomes, and what every couple should know when trying to conceive.→ Leave Us A Voice Message!Topics Discussed: → How can I naturally improve my fertility?→ What are the red flags for infertility?→ Does stress affect your ability to conceive?→ What is needle-free IVF and how does it work?→ How does age impact egg quality and conception?Sponsored By: → Be Well By Kelly Protein Powder & Essentials | Get $10 off your order with PODCAST10 at bewellbykelly.com.→ AG1 | Head to drinkag1.com/bewell to get a FREE Welcome Kit with the flavor of your choice that includes a 30 day supply of AGZ and a FREE frother. → Function | Visit www.functionhealth.com/BEWELL100 or use gift code BEWELL100 at sign-up to own your health.→ Maui Nui | Right now, Maui Nui is offering a free 12-pack of their jerky sticks with your first order of $79 or more. Just go to https://mauinuivenison.com/lp/kelly to grab yours. →WeNatal | You can use my link, wenatal.com/kelly, with any subscription order, to get a free one month supply of WeNatal's Omega DHA+ Fish Oil valued at 35 dollars.Timestamps: → 00:00:00 - Introduction → 00:04:38 - Becoming A Reproductive Specialist → 00:06:01 - Subspecialty board exams → 00:07:57 - Reproductive endocrinology → 00:09:55 - Know your medical history → 00:12:58 - Genetic testing → 00:14:15 - Fertility Red flags → 00:17:09 - the pituitary gland → 00:21:24 - Hormone dysregulation → 00:27:22 - Every motherhood journey is different → 00:34:51 - DNA fragmentation → 00:38:41 - insemination options → 00:43:40 - Metabolic vs genetic aging → 00:47:34 - Chromosomes & pregnancy loss → 00:49:09 - The IVF process → 00:54:37 - IVF & exercise → 00:59:12 - Egg retrieval & embryo creation → 01:05:05 - Needle free IVF → 01:07:11 - Wellness & lifestyle advice Check Out → IG: @SashaHakmanMD→ WebsiteCheck Out Kelly:→ Instagram→

New hope for families as a company introduces a new form of genetic testing that allows people going through IVF to screen their embryos in detail before implantation. Also, what to know about the rising price of gold and what it means for consumers who own or are shopping for gold jewelry. Plus, Shop TODAY lifestyle and fashion contributor Melissa Garcia shares a few helpful hacks to make life easier. And, chef Molly Yeh shares a peanut blossom cookie recipe perfect for young bakers. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

My guest is Konstantina Stankovic, MD, PhD, Professor and Chair of Otolaryngology at Stanford School of Medicine. She explains how hearing works and why hearing loss—affecting over 1.5 billion people—impacts people of all ages. We discuss how hearing loss impairs focus and increases the risk of cognitive decline, as well as the role of menopause and other biological milestones in hearing health. We share science-backed protocols to protect your hearing and highlight risks to avoid. And we discuss tinnitus—its causes and treatment options. AGZ: https://drinkagz.com/huberman Wealthfront*: https://wealthfront.com/huberman Our Place: https://fromourplace.com/huberman David: https://davidprotein.com/huberman Joovv: https://joovv.com/huberman LMNT: https://drinklmnt.com/huberman *This experience may not be representative of the experience of other clients of Wealthfront, and there is no guarantee that all clients will have similar experiences. Cash Account is offered by Wealthfront Brokerage LLC, Member FINRA/SIPC. The Annual Percentage Yield (“APY”) on cash deposits as of September 26, 2025, is representative, subject to change, and requires no minimum. Funds in the Cash Account are swept to partner banks where they earn the variable‭ APY. Promo terms and FDIC coverage conditions apply. Same-day withdrawal or instant payment transfers may be limited by destination institutions, daily transaction caps, and by participating entities such as Wells Fargo, the RTP® Network, and FedNow® Service. New Cash Account deposits are subject to a 2-4 day holding period before becoming available for transfer. Investment advisory services are provided by Wealthfront Advisers LLC, an SEC-registered investment adviser. Securities investments are not bank deposits, bank-guaranteed or FDIC-insured, and may lose value. 00:00 Konstantina Stankovic 03:27 Hearing Loss, How Hearing Works, Types of Hearing Loss 10:58 Sound Waves, High vs Low Frequency, Communication, Importance of Hearing 15:26 Sponsors: Wealthfront & Our Place 18:40 Sound Projection, Intensity, Speech; Moving Ears; Larger Ears 22:59 Sounds & Emotionality; Tinnitus 26:43 Painful Sounds, Hyperacusis, Phonophobia; Memory, Auditory Hallucinations 32:19 Concerts & Ringing in Ears, Hidden Hearing Loss; Tool: Safe Sound Threshold 39:15 Concerts & Protecting Hearing, Tools: Ear Plugs, Magnesium Threonate 43:44 Magnesium Food Sources & Supplements; Migraines & Tinnitus 47:30 Tinnitus; Hearing Loss, Genetic & Environmental Factors 53:19 Sponsors: AGZ by AG1 & David 56:04 Individualization; Tinnitus Examination & Treatment, Supplementation? 1:04:36 Headphones, Tough vs Tender Ears, Children, Tool: Safe Sound Levels 1:09:41 Compounded Damage, Concerts & Hearing Loss, Tool: Ear Plugs 1:12:59 Transitioning Environments, Hyperacusis; In-Utero Hearing 1:15:56 Dogs & Sea Animals, Sound Pollution 1:19:54 Hearing Loss, Dementia & Cognitive Decline; Tool: Slow Speech & Face Listener 1:26:26 Sponsor: Joovv 1:27:38 Lip Reading; AI-Enhanced Hearing Aids 1:30:12 Sleep, Tool: Earplugs; Hearing Yourself Speak, Superior Semicircular Canal Dehiscence 1:36:54 Hearing & Balance, Vibrations; Sound Therapy 1:42:05 Music, Dance, Hearing & Frequency Map; Cochlear Implants 1:48:20 Sponsor: LMNT 1:49:52 Hearing & Social-Cognitive Development, Mental Health; Cochlear Implants 1:56:07 Men vs Women, Estrogen; Hearing Loss, Environment, NSAIDs 2:01:52 Environmental Toxins, Heavy Metals, Plastics; Tool: Heating Plastic 2:06:39 Tool: Avoid Regular NSAIDs Use; Birds & Hair Cell Regeneration; Cancer 2:12:05 Head & Neck, Lymphatic System & Surgery 2:14:44 Adult Auditory Plasticity, Music & Language 2:17:37 Splitting of Senses, Podcasts, AI & Human Progress 2:22:20 Prevent Hearing Loss & Recap 2:25:09 Zero-Cost Support, YouTube, Spotify & Apple Follow, Reviews & Feedback, Sponsors, Protocols Book, Social Media, Neural Network Newsletter Learn more about your ad choices. Visit megaphone.fm/adchoices

These diseases - West Nile Virus, Lyme disease, and Rocky Mountain Spotted Fever - are named for the places where outbreaks happened. But they're also all things you get from being bitten by mosquitoes or ticks. Research: Balasubramanian, Chandana. “Rocky Mountain Spotted Fever (RMSF): The Deadly Tick-borne Disease That Inspired a Hit Movie.” Gideon. 9/1/2022. https://www.gideononline.com/blogs/rocky-mountain-spotted-fever/ Barbour AG, Benach JL2019.Discovery of the Lyme Disease Agent. mBio10:10.1128/mbio.02166-19.https://doi.org/10.1128/mbio.02166-19 Bay Area Lyme Foundation. “History of Lyme Disease.” https://www.bayarealyme.org/about-lyme/history-lyme-disease/ Caccone, Adalgisa. “Ancient History of Lyme Disease in North America Revealed with Bacterial Genomes.” Yale School of Medicine. 8/28/2017. https://medicine.yale.edu/news-article/ancient-history-of-lyme-disease-in-north-america-revealed-with-bacterial-genomes/ Chowning, William M. “Studies in Pyroplasmosis Hominis.("Spotted Fever" or "Tick Fever" of the Rocky Mountains.).” The Journal of Infectious Diseases. 1/2/1904. https://archive.org/details/jstor-30071629/page/n29/mode/1up Elbaum-Garfinkle, Shana. “Close to home: a history of Yale and Lyme disease.” The Yale journal of biology and medicine vol. 84,2 (2011): 103-8. Farris, Debbie. “Lyme disease older than human race.” Oregon State University. 5/29/2014. https://science.oregonstate.edu/IMPACT/2014/05/lyme-disease-older-than-human-race Galef, Julia. “Iceman Was a Medical Mess.” Science. 2/29/2012. https://www.science.org/content/article/iceman-was-medical-mess Gould, Carolyn V. “Combating West Nile Virus Disease — Time to Revisit Vaccination.” New England Journal of Medicine. Vol. 388, No. 18. 4/29/2023. https://www.nejm.org/doi/full/10.1056/NEJMp2301816 Harmon, Jim. “Harmon’s Histories: Montana’s Early Tick Fever Research Drew Protests, Violence.” Missoula Current. 7/20/2020. https://missoulacurrent.com/ticks/ Hayes, Curtis G. “West Nile Virus: Uganda, 1937, to New York City, 1999.” From West Nile Virus: Detection, Surveillance, and Control. New York : New York Academy of Sciences. 2001. https://archive.org/details/westnilevirusdet0951unse/ Jannotta, Sepp. “Robert Cooley.” Montana State University. 10/12/2012. https://www.montana.edu/news/mountainsandminds/article.html?id=11471 Johnston, B L, and J M Conly. “West Nile virus - where did it come from and where might it go?.” The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses vol. 11,4 (2000): 175-8. doi:10.1155/2000/856598 Lloyd, Douglas S. “Circular Letter #12 -32.” 8/3/1976. https://portal.ct.gov/-/media/departments-and-agencies/dph/dph/infectious_diseases/lyme/1976circularletterpdf.pdf Mahajan, Vikram K. “Lyme Disease: An Overview.” Indian dermatology online journal vol. 14,5 594-604. 23 Feb. 2023, doi:10.4103/idoj.idoj_418_22 MedLine Plus. “West Nile virus infection.” https://medlineplus.gov/ency/article/007186.htm National Institute of Allergy and Infectious Disease. “History of Rocky Mountain Labs (RML).” 8/16/2023. https://www.niaid.nih.gov/about/rocky-mountain-history National Institute of Allergy and Infectious Disease. “Rocky Mountain Spotted Fever.” https://www.niaid.nih.gov/diseases-conditions/rocky-mountain-spotted-fever Rensberger, Boyce. “A New Type of Arthritis Found in Lyme.” New York Times. 7/18/1976. https://www.nytimes.com/1976/07/18/archives/a-new-type-of-arthritis-found-in-lyme-new-form-of-arthritis-is.html?login=smartlock&auth=login-smartlock Rucker, William Colby. “Rocky Mountain Spotted Fever.” Washington: Government Printing Office. 1912. https://archive.org/details/101688739.nlm.nih.gov/page/ Sejvar, James J. “West Nile virus: an historical overview.” Ochsner journal vol. 5,3 (2003): 6-10. https://pmc.ncbi.nlm.nih.gov/articles/PMC3111838/ Smithburn, K.C. et al. “A Neurotropic Virus Isolated from the Blood of a Native of Uganda.” The American Journal of Tropical Medicine and Hygiene. Volume s1-20: Issue 4. 1940. Steere, Allen C et al. “The emergence of Lyme disease.” The Journal of clinical investigation vol. 113,8 (2004): 1093-101. doi:10.1172/JCI21681 Steere, Allen C. et al. “Historical Perspectives.” Zbl. Bakt. Hyg. A 263, 3-6 (1986 ). https://pdf.sciencedirectassets.com/281837/1-s2.0-S0176672486X80912/1-s2.0-S0176672486800931/main.pdf World Health Organization. “West Nile Virus.” 10/3/2017. https://www.who.int/news-room/fact-sheets/detail/west-nile-virus Xiao, Y., Beare, P.A., Best, S.M. et al. Genetic sequencing of a 1944 Rocky Mountain spotted fever vaccine. Sci Rep 13, 4687 (2023). https://doi.org/10.1038/s41598-023-31894-0 See omnystudio.com/listener for privacy information.